Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders

Molecular Psychiatry

Volumn 20, Issue 7, 2015, Pages 795-809

  Schubert, D ^a   Martens, G J M ^a   Kolk, S M ^a  

^a RADBOUD UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER; AUTISM; BRAIN DEVELOPMENT; CELL MIGRATION; CELL PROLIFERATION; DEVELOPMENTAL DISORDER; INTERNEURON; NEURAL STEM CELL; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REVIEW; SCHIZOPHRENIA; SYNAPSE; SYNAPTOGENESIS; ANIMAL; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; NEURODEVELOPMENTAL DISORDERS;

ANIMALS; HUMANS; NEURODEVELOPMENTAL DISORDERS; PREFRONTAL CORTEX;

EID: 84932193001     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.147     Document Type: Review

References (334)

1. Patel V, Boyce N, Collins PY, Saxena S, Horton R A renewed agenda for global mental health. Lancet 2011; 378: 1441-1442
2. Belfer ML. Child and adolescent mental disorders: the magnitude of the problem across the globe. J Child Psychol Psychiatry 2008; 49: 226-236
3. Mitchell SR, Reiss AL, Tatusko DH, Ikuta I, Kazmerski DB, Botti JA, et al. Neuroanatomic alterations and social and communication deficits in monozygotic twins discordant for autism disorder. Am J Psychiatry 2009; 166: 917-925
4. Shenton ME, Dickey CC, Frumin M, McCarley RW A review of MRI findings in schizophrenia. Schizophr Res 2001; 49: 1-52
5. Lesh TA, Niendam TA, Minzenberg MJ, Carter CS. Cognitive control deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology 2011; 36: 316-338
6. Casanova MF. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophrenia bulletin 1997; 23: 517-519
7. Arnsten AF. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev 2009; 10: 410-422
8. Arnsten AF. Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia. Int J Dev Neurosci 29: 215-223
9. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, et al. Grand challenges in global mental health. Nature 2011; 475: 27-30
10. Kendler KS, Neale MC. Endophenotype: a conceptual analysis. Mol Psychiatry 2010; 15: 789-797
11. Gamo NJ, Arnsten AF. Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders. Behav Neurosci 2012; 125: 282-296
12. Lewis DA, Curley AA, Glausier JR, Volk DW. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci 2012; 35: 57-67
13. Thompson-Schill SL, Bedny M, Goldberg RF. The frontal lobes and the regulation of mental activity. Curr Opin Neurobiol 2005; 15: 219-224
14. Egner T, Hirsch J. Cognitive control mechanisms resolve conflict through cortical amplification of task-relevant information. Nat Neurosci 2005; 8: 1784-1790
15. Etkin A, Egner T, Peraza DM, Kandel ER, Hirsch J. Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron 2006; 51: 871-882
16. Miller EK. The prefrontal cortex and cognitive control. Nat Rev 2000; 1: 59-65
17. Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Ann Rev Neurosci 2001; 24: 167-202
18. Summerfield C, Egner T, Greene M, Koechlin E, Mangels J, Hirsch J. Predictive codes for forthcoming perception in the frontal cortex. Science 2006; 314: 1311-1314
19. Duncan J. An adaptive coding model of neural function in prefrontal cortex. Nat Rev 2001; 2: 820-829
20. Mansouri FA, Tanaka K, Buckley MJ. Conflict-induced behavioural adjustment: a clue to the executive functions of the prefrontal cortex. Nat Rev 2009; 10: 141-152
21. Niwa M, Kamiya A, Murai R, Kubo K, Gruber AJ, Tomita K, et al. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 2010; 65: 480-489
22. Loos M, Mueller T, Gouwenberg Y, Wijnands R, van der Loo RJ, Birchmeier C, et al. Neuregulin-3 in the mouse medial prefrontal cortex regulates impulsive action. Biol Psychiatry 2014; 76: 648-655
23. Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S. Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet. 2004; 5: 725-738
24. Contestabile A, Benfenati F, Gasparini L. Communication breaks-down: from neurodevelopment defects to cognitive disabilities in Down syndrome. Prog Neurobiol 2010; 91: 1-22
25. Gardiner K, Herault Y, Lott IT, Antonarakis SE, Reeves RH, Dierssen M. Down syndrome: from understanding the neurobiology to therapy. J Neurosci 2010; 30: 14943-14945
26. van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu Rev Genet 2011; 45: 81-104
27. Chelly J, Mandel JL. Monogenic causes of X-linked mental retardation. Nat Rev Genet. 2001; 2: 669-680
28. Kim M, Ceman S. Fragile X mental retardation protein: past, present and future. Curr Protein Pept Sci 2012; 13: 358-371
29. Kleefstra T, Smidt M, Banning MJ, Oudakker AR, Van Esch H, de Brouwer AP, et al. Disruption of the gene euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J Med Genet 2005; 42: 299-306
30. Mercaldo V, Descalzi G, Zhuo M. Fragile X mental retardation protein in learningrelated synaptic plasticity. Mol Cells 2009; 28: 501-507
31. Cheng A, Haydar TF, Yarowsky PJ, Krueger BK. Concurrent generation of subplate and cortical plate neurons in developing trisomy 16 mouse cortex. Dev Neurosci 2004; 26: 255-265
32. Chakrabarti L, Galdzicki Z, Haydar TF. Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J Neurosci. 2007; 27: 11483-11495
33. Willemsen MH, Vissers LE, Willemsen MA, van Bon BW, Kroes T, de Ligt J, et al. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J Med Genet 49: 179-183
34. Pilz DT, Matsumoto N, Minnerath S, Mills P, Gleeson JG, Allen KM, et al. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum Mol Genet 1998; 7: 2029-2037
35. Rafalowska J, Dziewulska D, Podlecka A, Maslinska D. Early ontogenic disturbances in cell migration in mentally disabled adult. Clin Neuropathol 2001; 20: 13-18
36. Penagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H, et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 2011; 147: 235-246
37. Liu JS. Molecular genetics of neuronal migration disorders. Curr Neurol Neurosci Rep 11: 171-178
38. Alarcon JM, Malleret G, Touzani K, Vronskaya S, Ishii S, Kandel ER, et al. Chromatin acetylation, memory, and LTP are impaired in CBP+/ - mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 2004; 42: 947-959
39. Nobs L, Baranek C, Nestel S, Kulik A, Kapfhammer J, Nitsch C, et al. Stage-specific requirement for cyclin D1 in glial progenitor cells of the cerebral cortex. Glia 2014; 62: 829-839
40. DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, et al. The developmental neurobiology of autism spectrum disorder. J Neurosci. 2006; 26: 6897-6906
41. Grafodatskaya D, Chung B, Szatmari P, Weksberg R. Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry 2010; 49: 794-809
42. Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci 2008; 31: 137-145
43. Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L. Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry 2006; 11: 1, 18-28
44. Etkin A, Gyurak A, O'Hara R A neurobiological approach to the cognitive deficits of psychiatric disorders. Dialogues Clin Neurosci 2013; 15: 419-429
45. Bishop DV. Genes, cognition, and communication: insights from neurodevelopmental disorders. Ann NY Acad Sci. 2009; 1156: 1-18
46. Folia V, Udden J, Forkstam C, Ingvar M, Hagoort P, Petersson KM. Implicit learning and dyslexia. Ann NY Acad Sci. 2008; 1145: 132-150
47. Orban P, Lungu O, Doyon J. Motor sequence learning and developmental dyslexia. Ann NY Acad Sci. 2008; 1145: 151-172
48. Pennington BF, Bishop DV. Relations among speech, language, and reading disorders. Annu Rev Psychol 2009; 60: 283-306
49. Abrams DA, Lynch CJ, Cheng KM, Phillips J, Supekar K, Ryali S, et al. Underconnectivity between voice-selective cortex and reward circuitry in children with autism. Proc Natl Acad Sci USA. 2013; 110: 12060-12065
50. Vaccarino FM, Grigorenko EL, Smith KM, Stevens HE. Regulation of cerebral cortical size and neuron number by fibroblast growth factors: implications for autism. J Autism Dev Disord 2009; 39: 511-520
51. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 2005; 42: 318-321
52. Courchesne E, Campbell K, Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res. 2011; 1380: 138-145
53. Courchesne E, Pierce K, Schumann CM, Redcay E, Buckwalter JA, Kennedy DP, et al. Mapping early brain development in autism. Neuron 2007; 56: 399-413
54. Schumann CM, Bloss CS, Barnes CC, Wideman GM, Carper RA, Akshoomoff N, et al. Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J Neurosci. 2010; 30: 4419-4427
55. Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 2002; 52: 805-810
56. Zhang ZW, Zak JD, Liu H. MeCP2 is required for normal development of GABAergic circuits in the thalamus. J Neurophysiol 2010; 103: 2470-2481
57. Zikopoulos B, Barbas H. Changes in prefrontal axons may disrupt the network in autism. J Neurosci. 2010; 30: 14595-14609
58. Zikopoulos B, Barbas H. Altered neural connectivity in excitatory and inhibitory cortical circuits in autism. Front Hum Neurosci 2013; 7: 609
59. Medrihan L, Tantalaki E, Aramuni G, Sargsyan V, Dudanova I, Missler M, et al. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol 2008; 99: 112-121
60. Radyushkin K, Hammerschmidt K, Boretius S, Varoqueaux F, El-Kordi A, Ronnenberg A, et al. Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav 2009; 8: 416-425
61. Santini E, Huynh TN, MacAskill AF, Carter AG, Pierre P, Ruggero D, et al. Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature 2013; 493: 411-415
62. Testa-Silva G, Loebel A, Giugliano M, de Kock CP, Mansvelder HD, Meredith RM. Hyperconnectivity and slow synapses during early development of medial prefrontal cortex in a mouse model for mental retardation and autism. Cereb Cortex. 2012; 22: 1333-1342
63. Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J, et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 2010; 68: 368-376
64. Morgan JT, Chana G, Abramson I, Semendeferi K, Courchesne E, Everall IP. Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res. 2012; 1456: 72-81
65. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 2005; 57: 1215-1220
66. Liston C, Malter Cohen M, Teslovich T, Levenson D, Casey BJ. Atypical prefrontal connectivity in attention-deficit/hyperactivity disorder: pathway to disease or pathological end point? Biol Psychiatry 2011; 69: 1168-1177
67. Brennan AR, Arnsten AF. Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. Ann NY Acad Sci. 2008; 1129: 236-245
68. Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA. 2007; 104: 19649-19654
69. Maltezos S, Horder J, Coghlan S, Skirrow C, O'Gorman R, Lavender TJ, et al. Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study. Transl Psychiatry 2014; 4: e373
70. D'Agati E, Casarelli L, Pitzianti MB, Pasini A. Overflow movements and white matter abnormalities in ADHD. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 441-445
71. Xia S, Li X, Kimball AE, Kelly MS, Lesser I, Branch C. Thalamic shape and connectivity abnormalities in children with attention-deficit/hyperactivity disorder. Psychiatry Res. 2012; 204: 161-167
72. Hart H, Marquand AF, Smith A, Cubillo A, Simmons A, Brammer M, et al. Predictive neurofunctional markers of attention-deficit/hyperactivity disorder based on pattern classification of temporal processing. J Am Acad Child Adolesc Psychiatry 2014; 53: 569-78, e1
73. Arnsten AF. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry 2006; 67(Suppl 8): 7-12
74. Rommelse NN, Geurts HM, Franke B, Buitelaar JK, Hartman CA A review on cognitive and brain endophenotypes that may be common in autism spectrum disorder and attention-deficit/hyperactivity disorder and facilitate the search for pleiotropic genes. Neurosci Biobehav Rev 2011; 35: 1363-1396
75. Leo D, Sorrentino E, Volpicelli F, Eyman M, Greco D, Viggiano D, et al. Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD. Neurosci Biobehav Rev 2003; 27: 661-669
76. Miller EM, Pomerleau F, Huettl P, Gerhardt GA, Glaser PE. Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder. Psychopharmacology 2014; 231: 3019-3029
77. Fossella JA, Sommer T, Fan J, Pfaff D, Posner MI. Synaptogenesis and heritable aspects of executive attention. Ment Retard Dev Disabil Res Rev 2003; 9: 178-183
78. Kenar AN, Ay OI, Herken H, Erdal ME. Association of VAMP-2 and Syntaxin 1A genes with adult attention deficit hyperactivity disorder. Psychiatry Investig 2014; 11: 76-83
79. Hawi Z, Matthews N, Wagner J, Wallace RH, Butler TJ, Vance A, et al. DNA variation in the SNAP25 gene confers risk to ADHD and is associated with reduced expression in prefrontal cortex. PloS One 2013; 8: e60274
80. McCarthy SE, McCombie WR, Corvin A. Unlocking the treasure trove: from genes to schizophrenia biology. Schizophr Bull 2014; 40: 492-496
81. Lewis DA, Cruz D, Eggan S, Erickson S. Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia. Ann NY Acad Sci. 2004; 1021: 64-76
82. Connor CM, Guo Y, Akbarian S. Cingulate white matter neurons in schizophrenia and bipolar disorder. Biol Psychiatry 2009; 66: 486-493
83. Beneyto M, Lewis DA. Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry. Int J Dev Neurosci. 2011; 29: 295-304
84. Arnsten AF. Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia. Int J Dev Neurosci. 2011; 29: 215-223
85. Zierhut KC, Schulte-Kemna A, Kaufmann J, Steiner J, Bogerts B, Schiltz K. Distinct structural alterations independently contributing to working memory deficits and symptomatology in paranoid schizophrenia. Cortex 2012; 49: 1063-1072
86. Arnold SE, Talbot K, Hahn CG. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res 2005; 147: 319-345
87. Bernstein HG, Smalla KH, Durrschmidt D, Keilhoff G, Dobrowolny H, Steiner J, et al. Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. Neuromolecular Med. 2012; 14: 270-280
88. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57: 65-73
89. Bennett MR. Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss. Prog Neurobiol 2011; 95: 275-300
90. Glausier JR, Fish KN, Lewis DA. Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects. Mol Psychiatry 2014; 19: 30-36
91. Glausier JR, Lewis DA. Dendritic spine pathology in schizophrenia. Neuroscience 2013; 251: 90-107
92. Carlsson A. The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 2006; 39: S10-S14
93. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004; 74: 1-58
94. Gonzalez-Burgos G, Hashimoto T, Lewis DA. Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep 2010; 12: 335-344
95. Lewis DA, Gonzalez-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 2008; 33: 141-165
96. Volk DW, Lewis DA. Prefrontal cortical circuits in schizophrenia. Curr Top Behav Neurosci 2010; 4: 485-508
97. Rolls ET, Loh M, Deco G, Winterer G. Computational models of schizophrenia and dopamine modulation in the prefrontal cortex. Nat Rev 2008; 9: 696-709
98. Chen L, Perez SM, Lodge DJ. An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia. Dev Neurobiol. 2014; 74: 907-917
99. Deserno L, Sterzer P, Wustenberg T, Heinz A, Schlagenhauf F. Reduced prefrontal-parietal effective connectivity and working memory deficits in schizophrenia. J Neurosci. 2012; 32: 12-20
100. Elston GN. Cortex, cognition and the cell: new insights into the pyramidal neuron and prefrontal function. Cereb Cortex. 2003; 13: 1124-1138
101. Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex. 2000; 10: 206-219
102. Kellendonk C, Simpson EH, Kandel ER. Modeling cognitive endophenotypes of schizophrenia in mice. Trends Neurosci 2009; 32: 347-358
103. Jaaro-Peled H. Gene models of schizophrenia: DISC1 mouse models. Prog Brain Res 2009; 179: 75-86
104. van Loo KM, Martens GJ. Genetic and environmental factors in complex neurodevelopmental disorders. Curr Genomics 2007; 8: 429-444
105. Coolen MW, Van Loo KM, Van Bakel NN, Pulford DJ, Serneels L, De Strooper B, et al. Gene dosage effect on gamma-secretase component Aph-1b in a rat model for neurodevelopmental disorders. Neuron 2005; 45: 497-503
106. Van Schijndel JE, Van Zweeden M, Van Loo KM, Martens GJ. Gene expression profiling in brain regions of a rat model displaying schizophrenia-related features. Behav Brain Res 2010; 207: 476-479
107. van der Elst MC, Roubos EW, Ellenbroek BA, Veening JG, Cools AR. Apomorphinesusceptible rats and apomorphine-unsusceptible rats differ in the tyrosine hydroxylase-immunoreactive network in the nucleus accumbens core and shell. Exp Brain Res 2005; 160: 418-423
108. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci. 2002; 22: 389-395
109. Roullet FI, Crawley JN. Mouse models of autism: testing hypotheses about molecular mechanisms. Curr Top Behav Neurosci 2011; 7: 187-212
110. Moy SS, Nadler JJ. Advances in behavioral genetics: mouse models of autism. Mol Psychiatry 2008; 13: 4-26
111. Desbonnet L, Waddington JL, Tuathaigh CM. Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes? Behav Brain Res 2009; 204: 258-273
112. Johnstone M, Thomson PA, Hall J, McIntosh AM, Lawrie SM, Porteous DJ. DISC1 in schizophrenia: genetic mouse models and human genomic imaging. Schizophr Bull 2011; 37: 14-20
113. Sawa A. Genetic animal models for schizophrenia: advantages and limitations of genetic manipulation in drosophila, zebrafish, rodents, and primates. Prog Brain Res 2009; 179: 3-6
114. Chen J, Lipska BK, Weinberger DR. Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models. Biol Psychiatry 2006; 59: 1180-1188
115. Baek ST, Kerjan G, Bielas SL, Lee JE, Fenstermaker AG, Novarino G, et al. Off-Target effect of doublecortin family shRNA on neuronal migration associated with endogenous microRNA dysregulation. Neuron 2014; 82: 1255-1262
116. Kolk SM, de Mooij-Malsen AJ, Martens GJ. Spatiotemporal molecular approach of in utero electroporation to functionally decipher endophenotypes in neurodevelopmental disorders. Front Mol Neurosci 2011; 4: 37
117. Bissonette GB, Powell EM. Reversal learning and attentional set-shifting in mice. Neuropharmacology 2011; 62: 1168-1174
118. Bissonette GB, Martins GJ, Franz TM, Harper ES, Schoenbaum G, Powell EM. Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J Neurosci. 2008; 28: 11124-11130
119. Brigman JL, Rothblat LA. Stimulus specific deficit on visual reversal learning after lesions of medial prefrontal cortex in the mouse. Behav Brain Res 2008; 187: 405-410
120. Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 2006; 49: 603-615
121. Ben Abdallah NM, Fuss J, Trusel M, Galsworthy MJ, Bobsin K, Colacicco G, et al. The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia. Exp Neurol 2011; 227: 42-52
122. Chudasama Y. Animal models of prefrontal-executive function. Behav Neurosci 2011; 125: 327-343
123. Kolb B, Mychasiuk R, Muhammad A, Li Y, Frost DO, Gibb R. Experience and the developing prefrontal cortex. Proc Natl Acad Sci USA. 2012; 109: 17186-17193
124. Vieira C, Pombero A, Garcia-Lopez R, Gimeno L, Echevarria D, Martinez S. Molecular mechanisms controlling brain development: an overview of neuroepithelial secondary organizers. Int J Dev Biol 2010; 54: 7-20
125. Puelles L, Rubenstein JL. Forebrain gene expression domains and the evolving prosomeric model. Trends Neurosci 2003; 26: 469-476
126. Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B, et al. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 2006; 124: 393-405
127. Pombero A, Martinez S. Telencephalic morphogenesis during the process of neurulation: an experimental study using quail-chick chimeras. J Comp Neurol 2009; 512: 784-797
128. Rubenstein JL, Martinez S, Shimamura K, Puelles L. The embryonic vertebrate forebrain: the prosomeric model. Science (New York, NY 1994; 266: 578-580
129. Borello U, Pierani A. Patterning the cerebral cortex: traveling with morphogens. Curr Opin Genet Dev 2010; 20: 408-415
130. Lander AD. Morpheus unbound: reimagining the morphogen gradient. Cell 2007; 128: 245-256
131. O'Leary DD, Chou SJ, Sahara S. Area patterning of the mammalian cortex. Neuron 2007; 56: 252-269
132. Fukuchi-Shimogori T, Grove EA. Neocortex patterning by the secreted signaling molecule FGF8. Science (New York, NY 2001; 294: 1071-1074
133. Rubenstein JL. Research Review: Development of the cerebral cortex: implications for neurodevelopmental disorders. J Child Psychol Psychiatry 2010; 52: 339-355
134. Hebert JM, Hayhurst M, Marks ME, Kulessa H, Hogan BL, McConnell SK. BMP ligands act redundantly to pattern the dorsal telencephalic midline. Genesis 2003; 35: 214-219
135. Fernandes M, Gutin G, Alcorn H, McConnell SK, Hebert JM. Mutations in the BMP pathway in mice support the existence of two molecular classes of holoprosencephaly. Development (Cambridge, England) 2007; 134: 3789-3794
136. Hebert JM, Mishina Y, McConnell SK. BMP signaling is required locally to pattern the dorsal telencephalic midline. Neuron 2002; 35: 1029-1041
137. Rash BG, Grove EA. Patterning the dorsal telencephalon: a role for sonic hedgehog? J Neurosci 2007; 27: 11595-11603
138. Kuschel S, Ruther U, Theil T A disrupted balance between Bmp/Wnt and Fgf signaling underlies the ventralization of the Gli3 mutant telencephalon. Dev Biol 2003; 260: 484-495
139. Ohkubo Y, Chiang C, Rubenstein JL. Coordifnate regulation and synergistic actions of BMP4, SHH and FGF8 in the rostral prosencephalon regulate morphogenesis of the telencephalic and optic vesicles. Neuroscience 2002; 111: 1-17
140. Blaess S, Stephen D, Joyner AL. Gli3 coordinates three-dimensional patterning and growth of the tectum and cerebellum by integrating Shh and Fgf8 signaling. Development (Cambridge, England) 2008; 135: 2093-2103
141. Cholfin JA, Rubenstein JL. Frontal cortex subdivision patterning is coordinately regulated by Fgf8, Fgf17, and Emx2. J Comp Neurol 2008; 509: 144-155
142. Scearce-Levie K, Roberson ED, Gerstein H, Cholfin JA, Mandiyan VS, Shah NM, et al. Abnormal social behaviors in mice lacking Fgf17. Genes Brain Behav 2008; 7: 344-354
143. Shimogori T, Banuchi V, Ng HY, Strauss JB, Grove EA. Embryonic signaling centers expressing BMP, WNT and FGF proteins interact to pattern the cerebral cortex. Development (Cambridge, England) 2004; 131: 5639-5647
144. Shin DM, Korada S, Raballo R, Shashikant CS, Simeone A, Taylor JR, et al. Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice. J Neurosci. 2004; 24: 2247-2258
145. Thomson RE, Kind PC, Graham NA, Etherson ML, Kennedy J, Fernandes AC, et al. Fgf receptor 3 activation promotes selective growth and expansion of occipitotemporal cortex. Neural Dev 2009; 4: 4
146. Thomson RE, Pellicano F, Iwata T. Fibroblast growth factor receptor 3 kinase domain mutation increases cortical progenitor proliferation via mitogenactivated protein kinase activation. J Neurochem 2007; 100: 1565-1578
147. Stevens HE, Smith KM, Maragnoli ME, Fagel D, Borok E, Shanabrough M, et al. Fgfr2 is required for the development of the miedial prefrontal cortex and its connections with limbic circuits. J Neurosci. 2010; 30: 5590-5602
148. Muller Smith K, Fagel DM, Stevens HE, Rabenstein RL, Maragnoli ME, Ohkubo Y, et al. Deficiency in inhibitory cortical interneurons associates with hyperactivity in fibroblast growth factor receptor 1 mutant mice. Biol Psychiatry 2008; 63: 953-962
149. Inglis-Broadgate SL, Thomson RE, Pellicano F, Tartaglia MA, Pontikis CC, Cooper JD, et al. FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic development. Dev Biol 2005; 279: 73-85
150. Hoch RV, Rubenstein JL, Pleasure S. Genes and signaling events that establish regional patterning of the mammalian forebrain. Semin Cell Dev Biol 2009; 20: 378-386
151. Sur M, Rubenstein JL. Patterning and plasticity of the cerebral cortex. Science (New York, NY 2005; 310: 805-810
152. Mason I. Initiation to end point: the multiple roles of fibroblast growth factors in neural development. Nat Rev 2007; 8: 583-596
153. Schuurmans C, Guillemot F. Molecular mechanisms underlying cell fate specification in the developing telencephalon. Curr Opin Neurobiol 2002; 12: 26-34
154. Jessell TM. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat Rev Genet 2000; 1: 20-29
155. Goridis C, Rohrer H. Specification of catecholaminergic and serotonergic neurons. Nat Rev 2002; 3: 531-541
156. Hasegawa H, Ashigaki S, Takamatsu M, Suzuki-Migishima R, Ohbayashi N, Itoh N, et al. Laminar patterning in the developing neocortex by temporally coordinated fibroblast growth factor signaling. J Neurosci 2004; 24: 8711-8719
157. Chou SJ, Perez-Garcia CG, Kroll TT, O'Leary DD. Lhx2 specifies regional fate in Emx1 lineage of telencephalic progenitors generating cerebral cortex. Nat Neurosci 2009; 12: 1381-1389
158. Mangale VS, Hirokawa KE, Satyaki PR, Gokulchandran N, Chikbire S, Subramanian L, et al. Lhx2 selector activity specifies cortical identity and suppresses hippocampal organizer fate. Science (New York, NY 2008; 319: 304-309
159. Polleux F, Ince-Dunn G, Ghosh A. Transcriptional regulation of vertebrate axon guidance and synapse formation. Nat Rev 2007; 8: 331-340
160. Flames N, Pla R, Gelman DM, Rubenstein JL, Puelles L, Marin O. Delineation of multiple subpallial progenitor domains by the combinatorial expression of transcriptional codes. J Neurosci 2007; 27: 9682-9695
161. Uchida S, Hara K, Kobayashi A, Funato H, Hobara T, Otsuki K, et al. Early life stress enhances behavioral vulnerability to stress through the activation of REST4-mediated gene transcription in the medial prefrontal cortex of rodents. J Neurosci 2010; 30: 15007-15018
162. Rojas P, Joodmardi E, Hong Y, Perlmann T, Ogren SO. Adult mice with reduced Nurr1 expression: an animal model for schizophrenia. Mol Psychiatry 2007; 12: 756-766
163. Johnson MB, Kawasawa YI, Mason CE, Krsnik Z, Coppola G, Bogdanovic D, et al. Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 2009; 62: 494-509
164. Yang S, Wang K, Valladares O, Hannenhalli S, Bucan M. Genome-wide expression profiling and bioinformatics analysis of diurnally regulated genes in the mouse prefrontal cortex. Genome Biol 2007; 8: R247
165. Erraji-Benchekroun L, Underwood MD, Arango V, Galfalvy H, Pavlidis P, Smyrniotopoulos P, et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry 2005; 57: 549-558
166. Zhang YE, Landback P, Vibranovski MD, Long M. Accelerated recruitment of new brain development genes into the human genome. PLoS Biol 2011; 9: e1001179
167. Kriegstein AR, Noctor SC. Patterns of neuronal migration in the embryonic cortex. Trends Neurosci 2004; 27: 392-399
168. Noctor SC, Flint AC, Weissman TA, Dammerman RS, Kriegstein AR. Neurons derived from radial glial cells establish radial units in neocortex. Nature 2001; 409: 714-720
169. Storm EE, Garel S, Borello U, Hebert JM, Martinez S, McConnell SK, et al. Dose-dependent functions of Fgf8 in regulating telencephalic patterning centers. Development (Cambridge, England) 2006; 133: 1831-1844
170. Garel S, Huffman KJ, Rubenstein JL. Molecular regionalization of the neocortex is disrupted in Fgf8 hypomorphic mutants. Development (Cambridge, England) 2003; 130: 1903-1914
171. Raballo R, Rhee J, Lyn-Cook R, Leckman JF, Schwartz ML, Vaccarino FM. Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J Neurosci 2000; 20: 5012-5023
172. Sessa A, Mao CA, Hadjantonakis AK, Klein WH, Broccoli V. Tbr2 directs conversion of radial glia into basal precursors and guides neuronal amplification by indirect neurogenesis in the developing neocortex. Neuron 2008; 60: 56-69
173. Sessa A, Mao CA, Colasante G, Nini A, Klein WH, Broccoli V. Tbr2-positive intermediate (basal) neuronal progenitors safeguard cerebral cortex expansion by controlling amplification of pallial glutamatergic neurons and attraction of subpallial GABAergic interneurons. Genes Dev 2010; 24: 1816-1826
174. Arnold SJ, Huang GJ, Cheung AF, Era T, Nishikawa S, Bikoff EK, et al. The T-box transcription factor Eomes/Tbr2 regulates neurogenesis in the cortical subventricular zone. Genes Dev 2008; 22: 2479-2484
175. Sweeney NT, Tierney H, Feldheim DA. Tbr2 is required to generate a neural circuit mediating the pupillary light reflex. J Neurosci 2014; 34: 5447-5453
176. Kolk SM, Gunput RA, Tran TS, van den Heuvel DM, Prasad AA, Hellemons AJ, et al. Semaphorin 3F is a bifunctional guidance cue for dopaminergic axons and controls their fasciculation, channeling, rostral growth, and intracortical targeting. J Neurosci 2009; 29: 12542-12557
177. Kinast K, Peeters D, Kolk SM, Schubert D, Homberg JR. Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior. Front Cell Neurosci 2013; 7: 72
178. Popolo M, McCarthy DM, Bhide PG. Influence of dopamine on precursor cell proliferation and differentiation in the embryonic mouse telencephalon. Dev Neurosci 2004; 26: 229-244
179. Kriegstein A, Noctor S, Martinez-Cerdeno V. Patterns of neural stem and progenitor cell division may underlie evolutionary cortical expansion. Nat Rev 2006; 7: 883-890
180. Ayala R, Shu T, Tsai LH. Trekking across the brain: the journey of neuronal migration. Cell 2007; 128: 29-43
181. Rakic P. The radial edifice of cortical architecture: from neuronal silhouettes to genetic engineering. Brain Res Rev 2007; 55: 204-219
182. Knuesel I. Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Prog Neurobiol 2010; 91: 257-274
183. Gaiano N. Strange bedfellows: Reelin and Notch signaling interact to regulate cell migration in the developing neocortex. Neuron 2008; 60: 189-191
184. Lui JH, Hansen DV, Kriegstein AR. Development and evolution of the human neocortex. Cell 2011; 146: 18-36
185. LaMonica BE, Lui JH, Wang X, Kriegstein AR. OSVZ progenitors in the human cortex: an updated perspective on neurodevelopmental disease. Curr Opin Neurobiol 2012; 22: 747-753
186. Gertz CC, Lui JH, LaMonica BE, Wang X, Kriegstein AR. Diverse behaviors of outer radial glia in developing ferret and human cortex. J Neurosci 2014; 34: 2559-2570
187. Miyoshi G, Butt SJ, Takebayashi H, Fishell G. Physiologically distinct temporal cohorts of cortical interneurons arise from telencephalic Olig2-expressing precursors. J Neurosci 2007; 27: 7786-7798
188. Southwell DG, Nicholas CR, Basbaum AI, Stryker MP, Kriegstein AR, Rubenstein JL, et al. Interneurons from embryonic development to cell-based therapy. Science (New York, NY 2014; 344: 1240622
189. Cobos I, Long JE, Thwin MT, Rubenstein JL. Cellular patterns of transcription factor expression in developing cortical interneurons. Cereb Cortex 2006; 16: i82-i88
190. Le Magueresse C, Monyer H. GABAergic interneurons shape the functional maturation of the cortex. Neuron 2013; 77: 388-405
191. Tessier-Lavigne M, Goodman CS. The molecular biology of axon guidance. Science (New York, NY 1996; 274: 1123-1133
192. Dickson BJ. Molecular mechanisms of axon guidance. Science (New York, NY 2002; 298: 1959-1964
193. O'Donnell M, Chance RK, Bashaw GJ. Axon growth and guidance: receptor regulation and signal transduction. Annu Rev Neurosci 2009; 32: 383-412
194. Dudanova I, Klein R. Integration of guidance cues: parallel signaling and crosstalk. Trends Neurosci 2013; 36: 295-304
195. Kiryushko D, Berezin V, Bock E. Regulators of neurite outgrowth: role of cell adhesion molecules. Ann NY Acad Sci 2004; 1014: 140-154
196. Stoya G, Redies C, Schmid-Hertel N. Inversion of layer-specific cadherin expression profiles and maintenance of cytoarchitectonic areas in the allocortex of the reeler mutant mouse. J Comp Neurol 2014
197. Lai KO, Ip NY. Synapse development and plasticity: roles of ephrin/Eph receptor signaling. Curr Opin Neurobiol 2009; 19: 275-283
198. Tessier CR, Broadie K. Activity-dependent modulation of neural circuit synaptic connectivity. Front Mol Neurosci 2009; 2: 8
199. Vanderhaeghen P, Cheng HJ. Guidance molecules in axon pruning and cell death. Cold Spring Harbor Perspect Biol 2010; 2: a001859
200. Petanjek Z, Judas M, Kostovic I, Uylings HB. Lifespan alterations of basal dendritic trees of pyramidal neurons in the human prefrontal cortex: a layer-specific pattern. Cereb Cortex 2008; 18: 915-929
201. de Almeida J, Jourdan I, Murer MG, Belforte JE. Refinement of neuronal synchronization with gamma oscillations in the medial prefrontal cortex after adolescence. PloS One 2013; 8: e62978
202. Yang JM, Zhang J, Yu YQ, Duan S, Li XM. Postnatal development of 2 microcircuits involving fast-spiking interneurons in the mouse prefrontal cortex. Cereb Cortex 2014; 24: 98-109
203. Hoover WB, Vertes RP. Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct Funct 2007; 212: 149-179
204. George O, Koob GF. Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev 2010; 35: 232-247
205. Lisboa SF, Stecchini MF, Correa FM, Guimaraes FS, Resstel LB. Different role of the ventral medial prefrontal cortex on modulation of innate and associative learned fear. Neuroscience 2010; 171: 760-768
206. Diamond A. Biological and social influences on cognitive control processes dependent on prefrontal cortex. Prog Brain Res 2011; 189: 319-339
207. Thompson BM, Baratta MV, Biedenkapp JC, Rudy JW, Watkins LR, Maier SF. Activation of the infralimbic cortex in a fear context enhances extinction learning. Learn Mem 2010; 17: 591-599
208. Laroche S, Davis S, Jay TM. Plasticity at hippocampal to prefrontal cortex synapses: dual roles in working memory and consolidation. Hippocampus 2000; 10: 438-446
209. Little JP, Carter AG. Subcellular synaptic connectivity of layer 2 pyramidal neurons in the medial prefrontal cortex. J Neurosci 2012; 32: 12808-12819
210. Golmayo L, Nunez A, Zaborszky L. Electrophysiological evidence for the existence of a posterior cortical-prefrontal-basal forebrain circuitry in modulating sensory responses in visual and somatosensory rat cortical areas. Neuroscience 2003; 119: 597-609
211. Henny P, Jones BE. Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons. Eur J Neurosci 2008; 27: 654-670
212. Hauber W. Dopamine release in the prefrontal cortex and striatum: temporal and behavioural aspects. Pharmacopsychiatry 43: S32-S41
213. van Schouwenburg M, Aarts E, Cools R. Dopaminergic modulation of cognitive control: distinct roles for the prefrontal cortex and the basal ganglia. Curr Pharm Des 2010; 16: 2026-2032
214. Fitzgerald PJ A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex? Psychopharmacology 2011; 213: 171-182
215. Witteveen JS, Middelman A, van Hulten JA, Martens GJ, Homberg JR, Kolk SM. Lack of serotonin reuptake during brain development alters rostral rapheprefrontal network formation. Front Cell Neurosci 2013; 7: 143
216. Goto Y, O'Donnell P. Altered prefrontal cortex-nucleus accumbens information processing in a developmental animal model of schizophrenia. Ann NY Acad Sci 2003; 1003: 398-401
217. Goto Y, Grace AA. Limbic and cortical information processing in the nucleus accumbens. Trends Neurosci 2008; 31: 552-558
218. Sarter M, Hasselmo ME, Bruno JP, Givens B. Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res 2005; 48: 98-111
219. Del Arco A, Mora F. Neurotransmitters and prefrontal cortex-limbic system interactions: implications for plasticity and psychiatric disorders. J Neural Transm 2009; 116: 941-952
220. Zhang ZW, Burke MW, Calakos N, Beaulieu JM, Vaucher E. Confocal analysis of cholinergic and dopaminergic inputs onto pyramidal cells in the prefrontal cortex of rodents. Front Neuroanat 2010; 4: 21
221. Otani S, Daniel H, Roisin MP, Crepel F. Dopaminergic modulation of longterm synaptic plasticity in rat prefrontal neurons. Cereb Cortex 2003; 13: 1251-1256
222. Gabbott P, Headlam A, Busby S. Morphological evidence that CA1 hippocampal afferents monosynaptically innervate PV-containing neurons and NADPHdiaphorase reactive cells in the medial prefrontal cortex (Areas 25/32) of the rat. Brain Res 2002; 946: 314-322
223. Gabbott PL, Warner TA, Busby SJ. Amygdala input monosynaptically innervates parvalbumin immunoreactive local circuit neurons in rat medial prefrontal cortex. Neuroscience 2006; 139: 1039-1048
224. Rotaru DC, Barrionuevo G, Sesack SR. Mediodorsal thalamic afferents to layer III of the rat prefrontal cortex: synaptic relationships to subclasses of interneurons. J Comp Neurol 2005; 490: 220-238
225. Little JP, Carter AG. Synaptic mechanisms underlying strong reciprocal connectivity between the medial prefrontal cortex and basolateral amygdala. J Neurosci 2013; 33: 15333-15342
226. Ernst M, Fudge JL A developmental neurobiological model of motivated behavior: anatomy, connectivity and ontogeny of the triadic nodes. Neurosci Biobehav Reviews 2009; 33: 367-382
227. Ernst M, Pine DS, Hardin M. Triadic model of the neurobiology of motivated behavior in adolescence. Psychol Med 2006; 36: 299-312
228. Senn V, Wolff SB, Herry C, Grenier F, Ehrlich I, Grundemann J, et al. Long-range connectivity defines behavioral specificity of amygdala neurons. Neuron 2014; 81: 428-437
229. Heidbreder CA, Groenewegen HJ. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 2003; 27: 555-579
230. Gabbott PL, Warner TA, Jays PR, Salway P, Busby SJ. Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J Comp Neurol 2005; 492: 145-177
231. Dembrow NC, Chitwood RA, Johnston D. Projection-specific neuromodulation of medial prefrontal cortex neurons. J Neurosci 2010; 30: 16922-16937
232. Ding DC, Gabbott PL, Totterdell S. Differences in the laminar origin of projections from the medial prefrontal cortex to the nucleus accumbens shell and core regions in the rat. Brain Res 2001; 917: 81-89
233. Cholfin JA, Rubenstein JL. Genetic regulation of prefrontal cortex development and function. Novartis Found Symp. 2007; 288: 165-173, discussion 73-7, 276-81
234. Schell-Apacik C, Rivero M, Knepper JL, Roessler E, Muenke M, Ming JE. SONIC HEDGEHOG mutations causing human holoprosencephaly impair neural patterning activity. Hum Genet. 2003; 113: 170-177
235. Al-Ayadhi LY. Relationship between Sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders. Neurochem Res. 2012; 37: 394-400
236. Heussler HS, Suri M, Young ID, Muenke M. Extreme variability of expression of a Sonic Hedgehog mutation: attention difficulties and holoprosencephaly. Arch Dis Child. 2002; 86: 293-296
237. Raballo R, Rhee J, Lyn-Cook R, Leckman JF, Schwartz ML, Vaccarino FM. Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J Neurosci. 2000; 20: 5012-5023
238. Terwisscha van Scheltinga AF, Bakker SC, Kahn RS, Kas MJ. Fibroblast growth factors in neurodevelopment and psychopathology. Neuroscientist 2013; 19: 479-494
239. Hashimoto K, Shimizu E, Komatsu N, Nakazato M, Okamura N, Watanabe H, et al. Increased levels of serum basic fibroblast growth factor in schizophrenia. Psychiatry Res. 2003; 120: 211-218
240. Simonis N, Migeotte I, Lambert N, Perazzolo C, de Silva DC, Dimitrov B, et al. FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly. J Med Genet 2013; 50: 585-592
241. Gaughran F, Payne J, Sedgwick PM, Cotter D, Berry M. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res Bull 2006; 70: 221-227
242. Stachowiak MK, Kucinski A, Curl R, Syposs C, Yang Y, Narla S, et al. Schizophrenia: a neurodevelopmental disorder-integrative genomic hypothesis and therapeutic implications from a transgenic mouse model. Schizophr Res 2013; 143: 367-376
243. Mahieu-Caputo D, Sonigo P, Amiel J, Simon I, Aubry MC, Lemerrer M, et al. Prenatal diagnosis of sporadic Apert syndrome: a sequential diagnostic approach combining three-dimensional computed tomography and molecular biology. Fetal Diagn Ther. 2001; 16: 10-12
244. Padmanabhan V, Hegde AM, Rai K. Crouzon's syndrome: a review of literature and case report. Contemp Clin Dent 2011; 2: 211-214
245. Wentz E, Vujic M, Karrstedt EL, Erlandsson A, Gillberg C A case report of two male siblings with autism and duplication of Xq13-q21, a region including three genes predisposing for autism. European Child Adolesc Psychiatry 2014; 23: 329-336
246. Kaga Y, Shoemaker WJ, Furusho M, Bryant M, Rosenbluth J, Pfeiffer SE, et al. Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. J Neurosci. 2006; 26: 12339-12350
247. O'Donovan MC, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, et al. Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry 2009; 14: 30-36
248. Stevens HE, Su T, Yanagawa Y, Vaccarino FM. Prenatal stress delays inhibitory neuron progenitor migration in the developing neocortex. Psychoneuroendocrinology 2013; 38: 509-521
249. Theisen A, Rosenfeld JA, Shane K, McBride KL, Atkin JF, Gaba C, et al. Refinement of the region for split hand/foot malformation 5 on 2q31.1. Mol Syndromol 2010; 1: 262-271
250. Liu X, Novosedlik N, Wang A, Hudson ML, Cohen IL, Chudley AE, et al. The DLX1and DLX2 genes and susceptibility to autism spectrum disorders. Eur J Hum Genet 2009; 17: 228-235
251. Uchida T, Furukawa T, Iwata S, Yanagawa Y, Fukuda A. Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring. Transl Psychiatry 2014; 4: e371
252. Lazarus MS, Krishnan K, Huang ZJ. GAD67 Deficiency in parvalbumin interneurons produces deficits in inhibitory transmission and network disinhibition in mouse prefrontal cortex. Cereb Cortex 2013 (e-pub ahead of print
253. Bacchelli E, Blasi F, Biondolillo M, Lamb JA, Bonora E, Barnby G, et al. Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry 2003; 8: 916-924
254. Rabionet R, Jaworski JM, Ashley-Koch AE, Martin ER, Sutcliffe JS, Haines JL, et al. Analysis of the autism chromosome 2 linkage region: GAD1 and other candidate genes. Neurosci Lett. 2004; 372: 209-214
255. Buttenschon HN, Lauritsen MB, El Daoud A, Hollegaard M, Jorgensen M, Tvedegaard K, et al A population-based association study of glutamate decarboxylase 1 as a candidate gene for autism. J Neural Transm. 2009; 116: 381-388
256. Chang SC, Pauls DL, Lange C, Sasanfar R, Santangelo SL. Common genetic variation in the GAD1 gene and the entire family of DLX homeobox genes and autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 2011; 156: 233-239
257. Akbarian S, Huang HS. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 2006; 52: 293-304
258. Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry 2012; 17: 887-905
259. Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH, Mayhew MB, et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry 2007; 12: 854-869
260. Cherlyn SY, Woon PS, Liu JJ, Ong WY, Tsai GC, Sim K. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neurosci Biobehav Rev 2010; 34: 958-977
261. Cooper MA, Koleske AJ. Ablation of ErbB4 from excitatory neurons leads to reduced dendritic spine density in mouse prefrontal cortex. J Comp Neurol 2014; 522: 3351-3362
262. Ting AK, Chen Y, Wen L, Yin DM, Shen C, Tao Y, et al. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J Neurosci. 2011; 31: 15-25
263. Hou XJ, Ni KM, Yang JM, Li XM. Neuregulin 1/ErbB4 enhances synchronized oscillations of prefrontal cortex neurons via inhibitory synapses. Neuroscience 2014; 261: 107-117
264. Yang JM, Zhang J, Chen XJ, Geng HY, Ye M, Spitzer NC, et al. Development of GABA circuitry of fast-spiking basket interneurons in the medial prefrontal cortex of erbb4-mutant mice. J Neurosci. 2013; 33: 19724-19733
265. Kasnauskiene J, Ciuladaite Z, Preiksaitiene E, Utkus A, Peciulyte A, Kucinskas V A new single gene deletion on 2q34: ERBB4 is associated with intellectual disability. Am J Med Genet 2013; 161A: 1487-1490
266. Joshi D, Fullerton JM, Weickert CS. Elevated ErbB4 mRNA is related to interneuron deficit in prefrontal cortex in schizophrenia. J Psychiatr Res. 2014; 53: 125-132
267. Del Pino I, Garcia-Frigola C, Dehorter N, Brotons-Mas JR, Alvarez-Salvado E, Martinez de Lagran M, et al. Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron 2013; 79: 1152-1168
268. Buonanno A. The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits. Brain Res Bull 2010; 83: 122-131
269. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J. Molecular mechanisms of schizophrenia. Cell Physiol Biochem. 2007; 20: 687-702
270. Yonan AL, Palmer AA, Smith KC, Feldman I, Lee HK, Yonan JM, et al. Bioinformatic analysis of autism positional candidate genes using biological databases and computational gene network prediction. Genes Brain Behav 2003; 2: 303-320
271. Yonan AL, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA, et al A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet 2003; 73: 886-897
272. Neves-Pereira M, Muller B, Massie D, Williams JH, O'Brien PC, Hughes A, et al. Deregulation of EIF4E: a novel mechanism for autism. J Med Genet 2009; 46: 759-765
273. Gkogkas CG, Sonenberg N. Translational control and autism-like behaviors. Cell Logist 2013; 3: e24551
274. Krueger DD, Osterweil EK, Chen SP, Tye LD, Bear MF. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome. Proc Natl Acad Sci USA. 2011; 108: 2587-2592
275. Bhakar AL, Dolen G, Bear MF. The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci 2012; 35: 417-443
276. Irwin SA, Galvez R, Greenough WT. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex. 2000; 10: 1038-1044
277. De Rubeis S, Fernandez E, Buzzi A, Di Marino D, Bagni C. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis. Adv Exp Med Biol 2012; 970: 517-551
278. Maurin T, Zongaro S, Bardoni B. Fragile X Syndrome: from molecular pathology to therapy. Neurosci Biobehav Rev 2014 (in press
279. Rotschafer SE, Razak KA. Auditory processing in fragile x syndrome. Front Cell Neurosci 2014; 8: 19
280. Oddi D, Crusio WE, D'Amato FR, Pietropaolo S. Monogenic mouse models of social dysfunction: implications for autism. Behav Brain Res 2013; 251: 75-84
281. Tranfaglia MR. The psychiatric presentation of fragile x: evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome. Dev Neurosci 2011; 33: 337-348
282. Kramvis I, Mansvelder HD, Loos M, Meredith R. Hyperactivity, perseveration and increased responding during attentional rule acquisition in the Fragile X mouse model. Front Behav Neurosci 2013; 7: 172
283. Kim L, He L, Maaswinkel H, Zhu L, Sirotkin H, Weng W. Anxiety, hyperactivity and stereotypy in a zebrafish model of fragile X syndrome and autism spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry 2014; 55: 40-49
284. Kraan CM, Hocking DR, Georgiou-Karistianis N, Metcalfe SA, Archibald AD, Fielding J, et al. Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers. Am J Med Genet B Neuropsychiatr Genet 2014; 165: 41-51
285. Hunter JE, Epstein MP, Tinker SW, Abramowitz A, Sherman SL. The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance. Behav Genet 2012; 42: 415-422
286. Kovacs T, Kelemen O, Keri S. Decreased fragile X mental retardation protein (FMRP) is associated with lower IQ and earlier illness onset in patients with schizophrenia. Psychiatry Res. 2013; 210: 690-693
287. Fatemi SH, Folsom TD. The role of fragile X mental retardation protein in major mental disorders. Neuropharmacology 2011; 60: 1221-1226
288. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014; 506: 179-184
289. Yadav R, Gupta SC, Hillman BG, Bhatt JM, Stairs DJ, Dravid SM. Deletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors. PloS One 2012; 7: e32969
290. Griswold AJ, Ma D, Cukier HN, Nations LD, Schmidt MA, Chung RH, et al. Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-Associated pathways. Hum Mol Genet 2012; 21: 3513-3523
291. Guo SZ, Huang K, Shi YY, Tang W, Zhou J, Feng GY, et al A case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population. Schizophr Res 2007; 93: 385-390
292. Treutlein J, Muhleisen TW, Frank J, Mattheisen M, Herms S, Ludwig KU, et al. Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter. Schizophr Res 2009; 111: 123-130
293. Kolk SM, Gunput RA, Tran TS, van den Heuvel DM, Prasad AA, Hellemons AJ, et al. Semaphorin 3F is a bifunctional guidance cue for dopaminergic axons and controls their fasciculation, channeling, rostral growth, and intracortical targeting. J Neurosci. 2009; 29: 12542-12557
294. Brooks-Kayal A. Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children. Epilepsia 2011; 52: 13-20
295. Wu S, Yue W, Jia M, Ruan Y, Lu T, Gong X, et al. Association of the neuropilin-2 (NRP2) gene polymorphisms with autism in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 492-495
296. Iafrati J, Orejarena MJ, Lassalle O, Bouamrane L, Gonzalez-Campo C, Chavis P. Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway. Mol Psychiatry 2014; 19: 417-426
297. Zaki M, Shehab M, El-Aleem AA, Abdel-Salam G, Koeller HB, Ilkin Y, et al. Identification of a novel recessive RELN mutation using a homozygous balanced reciprocal translocation. Am J Med Genet 2007; 143A: 939-944
298. Folsom TD, Fatemi SH. The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 2013; 68: 122-135
299. Bartlett CW, Gharani N, Millonig JH, Brzustowicz LM. Three autism candidate genes: a synthesis of human genetic analysis with other disciplines. Int J Dev Neurosci. 2005; 23: 221-234
300. Fatemi SH. The role of Reelin in pathology of autism. Mol Psychiatry 2002; 7: 919-920
301. Fatemi SH. Reelin glycoprotein in autism and schizophrenia. Int Rev Neurobiol. 2005; 71: 179-187
302. Lakatosova S, Ostatnikova D. Reelin and its complex involvement in brain development and function. Int J Biochem Cell Biol. 2012; 44: 1501-1504
303. Frotscher M. Role for Reelin in stabilizing cortical architecture. Trends Neurosci 2010; 33: 407-414
304. Zhang W, Peterson M, Beyer B, Frankel WN, Zhang ZW. Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures. J Neurosci. 2014; 34: 2754-2763
305. Francke U. Mechanisms of disease: neurogenetics of MeCP2 deficiency. Nat Clin Pract Neurol. 2006; 2: 212-221
306. Samaco RC, Neul JL. Complexities of Rett syndrome and MeCP2. J Neurosci. 2011; 31: 7951-7959
307. Lanz TA, Guilmette E, Gosink MM, Fischer JE, Fitzgerald LW, Stephenson DT, et al. Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action. Mol Autism 2013; 4: 45
308. Suter B, Treadwell-Deering D, Zoghbi HY, Glaze DG, Neul JL. Brief report: MECP2 mutations in people without Rett syndrome. J Autism Dev Disord 2014; 44: 703-711
309. Neul JL. The relationship of Rett syndrome and MECP2 disorders to autism. Dialogues Clin Neurosci 2012; 14: 253-262
310. McCarthy SE, Gillis J, Kramer M, Lihm J, Yoon S, Berstein Y, et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry 2014; 19: 652-658
311. Piton A, Gauthier J, Hamdan FF, Lafreniere RG, Yang Y, Henrion E, et al. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry 2011; 16: 867-880
312. Xu B, Goldman JS, Rymar VV, Forget C, Lo PS, Bull SJ, et al. Critical roles for the netrin receptor deleted in colorectal cancer in dopaminergic neuronal precursor migration, axon guidance, and axon arborization. Neuroscience 2010; 169: 932-949
313. Manitt C, Eng C, Pokinko M, Ryan RT, Torres-Berrio A, Lopez JP, et al. Dcc orchestrates the development of the prefrontal cortex during adolescence and is altered in psychiatric patients. Transl Psychiatry 2013; 3: e338
314. Grant A, Fathalli F, Rouleau G, Joober R, Flores C. Association between schizophrenia and genetic variation in DCC: a case-control study. Schizophr Res. 2012; 137: 26-31
315. El-Hassar L, Simen AA, Duque A, Patel KD, Kaczmarek LK, Arnsten AF, et al. Disrupted in schizophrenia 1 modulates medial prefrontal cortex pyramidal neuron activity through cAMP regulation of transient receptor potential C and smallconductance K channels. Biol Psychiatry 2014; 76: 476-485
316. Kilpinen H, Ylisaukko-Oja T, Hennah W, Palo OM, Varilo T, Vanhala R, et al. Association of DISC1 with autism and Asperger syndrome. Mol Psychiatry 2008; 13: 187-196
317. Zheng F, Wang L, Jia M, Yue W, Ruan Y, Lu T, et al. Evidence for association between disrupted-in-Schizophrenia 1 (DISC1) gene polymorphisms and autism in Chinese Han population: a family-based association study. Behav Brain Funct. 2011; 7: 14
318. Kenny EM, Cormican P, Furlong S, Heron E, Kenny G, Fahey C, et al. Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol Psychiatry 2013; 19: 872-879
319. Kalkman HO A review of the evidence for the canonical Wnt pathway in autism spectrum disorders. Mol Autism 2012; 3: 10
320. Jacobsen KK, Halmoy A, Sanchez-Mora C, Ramos-Quiroga JA, Cormand B, Haavik J, et al. DISC1 in adult ADHD patients: an association study in two European samples. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 227-234
321. Narayan S, Nakajima K, Sawa A. DISC1: a key lead in studying cortical development and associated brain disorders. Neuroscientist 2013; 19: 451-464
322. Hikida T, Gamo NJ, Sawa A. DISC1 as a therapeutic target for mental illnesses. Expert Opin Ther Targets. 2012; 16: 1151-1160
323. Duff BJ, Macritchie KA, Moorhead TW, Lawrie SM, Blackwood DH. Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res 2013; 147: 1-13
324. Drerup JM, Hayashi K, Cui H, Mettlach GL, Long MA, Marvin M, et al. Attentiondeficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35. Biol Psychiatry. 2010; 68: 1163-1171
325. Ramos-Miguel A, Meana JJ, Garcia-Sevilla JA. Cyclin-dependent kinase-5 and p35/p25 activators in schizophrenia and major depression prefrontal cortex: basal contents and effects of psychotropic medications. Int J Neuropsychopharmacol. 2013; 16: 683-689
326. Engmann O, Hortobagyi T, Pidsley R, Troakes C, Bernstein HG, Kreutz MR, et al. Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. Brain 2011; 134: 2408-2421
327. Whitwell JL, Josephs KA, Avula R, Tosakulwong N, Weigand SD, Senjem ML, et al. Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD. Neurology 2011; 77: 866-874
328. Gregor A, Krumbiegel M, Kraus C, Reis A, Zweier C. De novo triplication of the MAPT gene from the recurrent 17q21.31 microdeletion region in a patient with moderate intellectual disability and various minor anomalies. Am J Med Genet A 2012; 158A: 1765-1770
329. Rovelet-Lecrux A, Campion D. Copy number variations involving the microtubule-Associated protein tau in human diseases. Biochem Soc Trans. 2012; 40: 672-676
330. Sapir T, Frotscher M, Levy T, Mandelkow EM, Reiner O. Tau's role in the developing brain: implications for intellectual disability. Hum Mol Genet. 2012; 21: 1681-1692
331. Kitsiou-Tzeli S, Frysira H, Giannikou K, Syrmou A, Kosma K, Kakourou G, et al. Microdeletion and microduplication 17q21.31 plus an additional CNV, in patients with intellectual disability, identified by array-CGH. Gene 2012; 492: 319-324
332. Runker AE, O'Tuathaigh C, Dunleavy M, Morris DW, Little GE, Corvin AP, et al. Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology. PloS One 2011; 6: e26488
333. Bosia M, Anselmetti S, Pirovano A, Ermoli E, Marino E, Bramanti P, et al. HTTLPR functional polymorphism in schizophrenia: executive functions versus sustained attention dissociation. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 81-85
334. Lin C, Tang W, Hu J, Gao L, Huang K, Xu Y, et al. Haplotype analysis confirms association of the serotonin transporter (5-HTT) gene with schizophrenia in the Han Chinese population. Neurosci Lett. 2009; 453: 210-213